{"gene":"GRK3","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1997,"finding":"GRK3 is required for agonist-induced desensitization of odorant receptors in the olfactory epithelium; GRK3 knockout mice lack fast agonist-induced desensitization and show markedly reduced cAMP generation following odorant stimulation.","method":"GRK3 knockout mice, cilia preparation cAMP assay, odorant stimulation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype, replicated across multiple stimuli","pmids":["9325250"],"is_preprint":false},{"year":1998,"finding":"Cardiac overexpression of GRK3 selectively attenuates thrombin-induced p42/p44 MAP kinase activation but does not desensitize beta-adrenergic or angiotensin II receptors in vivo, demonstrating distinct substrate specificity of GRK3 in the heart.","method":"Transgenic mice with cardiac-specific GRK3 overexpression, in vivo hemodynamic measurements, MAP kinase activation assays","journal":"The American journal of physiology","confidence":"High","confidence_rationale":"Tier 2 — transgenic animal model with multiple receptor/signaling readouts","pmids":["9746479"],"is_preprint":false},{"year":2001,"finding":"GRK3 mediates homologous desensitization of CRF1 receptors; GRK3 antisense knockdown (~50% reduction in GRK3 protein) inhibited CRF1 receptor desensitization by ~65% in Y-79 cells, while PKA inhibition had no effect.","method":"GRK3 antisense oligonucleotide and antisense cDNA transfection, cAMP accumulation assay, heparin GRK inhibition","journal":"American journal of physiology. Regulatory, integrative and comparative physiology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple antisense approaches with functional readout, single lab","pmids":["11247813"],"is_preprint":false},{"year":2003,"finding":"GRK3-mediated mechanisms are required for electrophysiological and behavioral tolerance to the high-efficacy opioid fentanyl but not morphine; GRK3 knockout mice show significantly reduced fentanyl tolerance in hippocampal slices and antinociceptive assays.","method":"GRK3 knockout mice, hippocampal slice electrophysiology, hot-plate antinociception assay","journal":"British journal of pharmacology","confidence":"High","confidence_rationale":"Tier 2 — clean KO with both in vitro and in vivo phenotypic readouts","pmids":["14662727"],"is_preprint":false},{"year":2003,"finding":"Beta2-adrenoceptor activation upregulates GRK3 expression, which in turn mediates desensitization and downregulation of alpha2A-adrenoceptors; GRK2/3 antisense DNA blocked chronic adrenaline-induced alpha2A-AR desensitization.","method":"GRK2/3 antisense DNA, receptor binding assay, beta-AR antagonist propranolol blockade, immunoblotting","journal":"British journal of pharmacology","confidence":"Medium","confidence_rationale":"Tier 3 — antisense knockdown with functional assay, single lab","pmids":["12642394"],"is_preprint":false},{"year":2005,"finding":"ATP stimulates GRK3 binding to the P2X7 receptor, followed by beta-arrestin-2 and dynamin recruitment, leading to clathrin-dependent internalization of the receptor.","method":"Western blot co-immunoprecipitation, pore formation assay, immunofluorescence of beta-arrestin-2 redistribution","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 3 — single Co-IP/pulldown evidence for GRK3-P2X7 interaction, single lab","pmids":["15728711"],"is_preprint":false},{"year":2006,"finding":"KOR activation of p38 MAPK requires GRK3-mediated phosphorylation of serine-369 on KOR and subsequent arrestin3 recruitment; p38 activation was absent in GRK3 knockout neurons and astrocytes, and was rescued by dominant-positive arrestin3-(R170E).","method":"GRK3 knockout mice, AtT-20 cells with KSA mutant receptor, dominant-positive arrestin3-(R170E) transfection, phospho-p38 immunolabeling, siRNA for arrestin3","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches (KO mice, receptor mutant, dominant-positive arrestin, siRNA) across two cell types","pmids":["16648139"],"is_preprint":false},{"year":2006,"finding":"Mu opioid receptor activation of ERK1/2 in striatal neurons requires GRK3 and arrestin3; ERK1/2 activation by fentanyl was absent in GRK3-/- neurons and restored by dominant-positive arrestin3-(R170E), and was not induced by morphine (lower efficacy) unless dominant-positive arrestin was co-expressed.","method":"GRK3 knockout mice, MOR knockout mice, dominant-positive arrestin3-(R170E) transfection, siRNA for arrestin3, MEK inhibitor U0126, ERK1/2 phosphorylation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches (KO, dominant-positive arrestin, siRNA, inhibitor) in primary neurons","pmids":["16982618"],"is_preprint":false},{"year":2006,"finding":"Chronic treatment with lithium or carbamazepine (but not valproate) increases translocation of GRK3 from cytosol to membrane fraction in rat frontal cortex.","method":"Immunoblotting of membrane and cytosol fractions from drug-treated rats","journal":"Biological psychiatry","confidence":"Low","confidence_rationale":"Tier 3 — single method (immunoblot), single lab, no direct mechanistic follow-up","pmids":["16697355"],"is_preprint":false},{"year":2007,"finding":"CRF activates CRF1 receptors to upregulate GRK3 expression via an ERK1/2-mediated mechanism involving Sp-1 and Ap-2 transcription factors in CATH.a cells (locus coeruleus-derived).","method":"ERK1/2 inhibitors, transcription factor activity assays (Sp-1, Ap-2), GRK3 mRNA/protein quantification","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 3 — functional pathway inhibition with transcription factor identification, single lab","pmids":["17583697"],"is_preprint":false},{"year":2007,"finding":"Inhibition of cardiac GRK3 (via expression of GRK3ct) enhances alpha1-adrenergic receptor-mediated ERK1/2 activation in cardiac myocytes and increases systolic blood pressure and cardiac output in vivo, demonstrating that GRK3 specifically desensitizes alpha1-adrenergic receptors in the heart.","method":"Transgenic mice expressing GRK3ct competitive inhibitor, cardiac myocyte ERK1/2 assay, conductance micromanometry, tail-cuff plethysmography, radiotelemetric blood pressure recording","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — transgenic competitive inhibitor with multiple in vivo functional readouts","pmids":["18165681"],"is_preprint":false},{"year":2008,"finding":"GRK3 specifically regulates CXCL12-promoted internalization and desensitization of CXCR4; GRK3 silencing in control leukocytes phenocopied impaired CXCR4 attenuation seen in WHIM syndrome cells, and GRK3 overexpression in WHIM patient cells restored normal CXCR4 internalization and chemotaxis.","method":"GRK3 siRNA knockdown, GRK3 overexpression in patient leukocytes and fibroblasts, CXCR4 internalization assay, chemotaxis assay","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — reciprocal gain/loss-of-function with defined cellular phenotype, patient cell validation","pmids":["18274673"],"is_preprint":false},{"year":2009,"finding":"The C-terminus of GRK3 (GRK3ct) fused to fluorescent reporters binds free Gbetagamma dimers but not intact heterotrimers, enabling real-time reporting of G protein heterotrimer dissociation; using this probe, heterotrimer dissociation in living cells was shown to occur in less than 100 ms.","method":"FRET/BRET with GRK3ct fusion proteins and venus-labeled Gbetagamma, live-cell imaging, kinetic analysis","journal":"Cellular signalling","confidence":"High","confidence_rationale":"Tier 1-2 — reconstitution of GRK3ct-Gbetagamma interaction with FRET/BRET, multiple controls","pmids":["19258039"],"is_preprint":false},{"year":2014,"finding":"GRK3 promotes prostate cancer metastasis and angiogenesis, at least in part through downregulation of thrombospondin-1 and plasminogen activator inhibitor type 2; GRK3 is necessary for survival/proliferation of metastatic cells and sufficient to promote primary tumor growth in mouse xenograft models.","method":"RNAi screen, cDNA overexpression screen, mouse xenograft models, angiogenesis assays, protein expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo gain/loss of function with mechanistic targets identified, single lab","pmids":["24434559"],"is_preprint":false},{"year":2015,"finding":"GRK3 suppresses L-DOPA-induced dyskinesia via its RGS homology (RH) domain, which binds striatal Gq; kinase-dead GRK3 retains suppressive activity, but GRK3 with disabled RH domain does not, indicating the RH domain mediates Gq inhibition independently of kinase activity.","method":"Viral vector-mediated overexpression and microRNA knockdown in hemiparkinsonian rats, domain mutant analysis, Gq binding assay, ΔFosB immunohistochemistry","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 — domain dissection with multiple mutants, in vivo model, and direct binding of RH domain to Gq","pmids":["26043205"],"is_preprint":false},{"year":2016,"finding":"CREB directly targets and induces GRK3 transcription; GRK3 promotes neuroendocrine differentiation of prostate cancer cells in a kinase activity-dependent manner, and GRK3 silencing blocks CREB-induced neuroendocrine differentiation.","method":"ChIP/promoter analysis for CREB binding, GRK3 overexpression with kinase-dead controls, siRNA knockdown, NE marker expression assays","journal":"Oncotarget","confidence":"Medium","confidence_rationale":"Tier 2 — direct CREB-GRK3 promoter targeting plus kinase-activity-dependent functional assay, single lab","pmids":["27191986"],"is_preprint":false},{"year":2019,"finding":"RKIP binds specifically to the N-termini of GRK2 and GRK3 (not GRK5); the isolated N-terminal domains (GRK2/3 residues 1-185) interact directly with beta2-AR, prevent its phosphorylation and internalization, and increase receptor signaling and cardiomyocyte contractility.","method":"Co-immunoprecipitation, pull-down assays, beta2-AR phosphorylation assay, receptor internalization assay, cardiomyocyte contractility measurement","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 — Co-IP and pulldown with functional receptor and contractility assays, single lab","pmids":["31604529"],"is_preprint":false},{"year":2020,"finding":"GRK3 is recruited to chemokine-stimulated ACKR4 prior to beta-arrestins, and GRK2/3 inhibition partially blocks steady-state and chemokine-driven beta-arrestin recruitment to ACKR4, placing GRK3 upstream of beta-arrestin in ACKR4 trafficking.","method":"BRET-based GRK and beta-arrestin recruitment assays, GRK2/3 pharmacological inhibition, ACKR4 C-terminus deletion, fluorescent chemokine uptake assay","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 3 — multiple BRET and functional assays in single lab establishing recruitment hierarchy","pmids":["32391018"],"is_preprint":false},{"year":2020,"finding":"GRK2 and GRK3 are both required for mu-opioid receptor internalization and beta-arrestin2 recruitment; GRK2 contributes more than GRK3, and a GRK2/3-independent component of beta-arrestin2 recruitment exists at the plasma membrane.","method":"CRISPR/Cas9 knockout of GRK2, GRK3, or both in HEK293 cells; rescue expression; CMPD101 pharmacological inhibition; BRET-based beta-arrestin2 recruitment; flow cytometry internalization assay","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1-2 — CRISPR KO with rescue, pharmacological validation, multiple agonists and orthogonal readouts","pmids":["33060647"],"is_preprint":false},{"year":2021,"finding":"GRK3 deficiency in mice leads to elevated brain IL-1β, increased kynurenic acid turnover, hyper-responsiveness to D-amphetamine, elevated spontaneous firing of midbrain dopamine neurons, and disruption in prepulse inhibition, linking GRK3 to immune/glial activation and dopaminergic dysregulation.","method":"Grk3-/- mice, behavioral assays, electrophysiology, biochemical (IL-1β, KYNA measurements), molecular imaging","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods in KO mice, single lab","pmids":["33976392"],"is_preprint":false},{"year":2023,"finding":"GRK3 phosphorylates HDAC2 at serine 394, enhancing HDAC2's epigenetic repression of TSP1 and REST, thereby promoting angiogenesis and neuroendocrine differentiation in prostate cancer.","method":"Co-IP, phosphorylation assay (GRK3-HDAC2 at S394), ChIP, luciferase reporter assay, siRNA/overexpression, in vivo xenograft","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 — direct phosphorylation of HDAC2 by GRK3 identified with multiple downstream functional assays, single lab","pmids":["37543278"],"is_preprint":false},{"year":2023,"finding":"GRK3 deficiency enhances osteoclastogenesis and proliferation of hematopoietic osteoclast precursors in vitro and in vivo; aged Grk3-/- mice develop bone lesions resembling Paget's Disease of Bone.","method":"Grk3-/- mice, in vitro osteoclast differentiation assay, flow cytometry of hematopoietic precursors, histological analysis","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse model with multiple cellular and in vivo phenotypic readouts, single lab","pmids":["37048054"],"is_preprint":false},{"year":2024,"finding":"GRK3 plays a distinct role in platelet GPCR desensitization: GRK3-/- platelets show potentiated aggregation and secretion in response to multiple GPCR agonists (including Gq-, Gi-, and Gz-coupled receptors) but not to the non-GPCR agonist collagen; GRK3-/- mice show shorter tail bleeding times.","method":"GRK3 knockout mice, platelet aggregation assay, dense granule secretion assay, AKT and ERK phosphorylation, tail bleeding time","journal":"Thrombosis and haemostasis","confidence":"High","confidence_rationale":"Tier 2 — clean KO with multiple agonist/receptor readouts and in vivo hemostasis assay","pmids":["39419098"],"is_preprint":false},{"year":2024,"finding":"Gβ5 selectively distinguishes GRK3 from GRK2 and enables GRK3 recruitment to the plasma membrane upon MOR activation; GRK3 is recruited to confined membrane domains enriched in Gβ5 (via single-molecule imaging), and oliceridine (a G-protein-biased MOR agonist) selectively activates GRK3-mediated beta-arrestin recruitment via Gαz-Gβ5 signaling.","method":"Multiple CRISPR-edited cell lines, BRET/FRET functional assays, single-molecule imaging, particle diffusion analysis","journal":"European journal of pharmacology","confidence":"High","confidence_rationale":"Tier 1-2 — single-molecule imaging, CRISPR KO of specific Gβ subunits, multiple orthogonal assays","pmids":["39579957"],"is_preprint":false},{"year":2007,"finding":"GRK3 regulates GRK2 protein levels in U937 cells via a mechanism involving inositol phosphate (InsP) upregulation; GRK3 antisense knockdown decreased GRK2 levels, establishing a novel cross-regulatory mechanism between GRK family members.","method":"Antisense knockdown of GRK3, immunoblotting for GRK2, InsP measurement","journal":"Biochemical pharmacology","confidence":"Low","confidence_rationale":"Tier 3 — single method (antisense + immunoblot), indirect mechanism, single lab","pmids":["17433264"],"is_preprint":false},{"year":2025,"finding":"GRK2, GRK3, and GRK6 are all important for FPR1 internalization in neutrophil-like cells, as identified by genome-wide CRISPR/Cas9 screens; FPR1 uses multiple endocytic pathways since cells lacking beta-arrestins show strong but incomplete internalization defects.","method":"Genome-wide CRISPR/Cas9 screens, FPR1 surface expression and internalization assays, beta-arrestin knockout validation","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — genome-wide screen with orthogonal validation, preprint","pmids":["bio_10.1101_2025.04.21.649864"],"is_preprint":true}],"current_model":"GRK3 is a serine/threonine GPCR kinase that phosphorylates activated GPCRs (including opioid, odorant, adrenergic, CRF1, CXCR4, and platelet receptors) to promote beta-arrestin recruitment and receptor desensitization/internalization, and additionally signals through its RGS homology domain to inhibit Gq, while its C-terminal Gbetagamma-binding domain is used to probe G protein heterotrimer dissociation dynamics, and its kinase activity can phosphorylate non-GPCR substrates such as HDAC2 to regulate epigenetic programs in cancer."},"narrative":{"teleology":[{"year":1997,"claim":"Establishing that GRK3 is a physiologically essential GPCR kinase for sensory receptor desensitization resolved whether GRK2 and GRK3 had redundant functions in vivo.","evidence":"GRK3 knockout mice showed abolished fast odorant-induced desensitization and reduced cAMP generation in olfactory cilia","pmids":["9325250"],"confidence":"High","gaps":["Whether GRK3 phosphorylation sites on odorant receptors were mapped","Whether GRK2 can partially compensate in olfactory neurons over longer timescales"]},{"year":1998,"claim":"Demonstrating cardiac substrate selectivity of GRK3 established that GRK isoforms have non-overlapping receptor preferences even within the same tissue.","evidence":"Transgenic cardiac GRK3 overexpression attenuated thrombin-induced MAPK signaling but not β-adrenergic or angiotensin II receptor responses in mouse heart","pmids":["9746479"],"confidence":"High","gaps":["Identity of the thrombin receptor (PAR) phosphorylation sites targeted by GRK3","Whether endogenous GRK3 levels limit thrombin signaling under physiological conditions"]},{"year":2001,"claim":"Identifying GRK3 as the kinase mediating CRF1 receptor desensitization extended its substrate repertoire to stress-related neuropeptide receptors.","evidence":"GRK3 antisense knockdown inhibited CRF1 desensitization by ~65% in Y-79 cells while PKA inhibition had no effect","pmids":["11247813"],"confidence":"Medium","gaps":["Awaits confirmation by genetic knockout or CRISPR approaches","CRF1 phosphorylation sites targeted by GRK3 not mapped"]},{"year":2003,"claim":"Showing that GRK3 is required for tolerance to high-efficacy but not low-efficacy opioids revealed an agonist-efficacy threshold for GRK3-dependent desensitization, a principle later extended to MOR-ERK signaling.","evidence":"GRK3 knockout mice retained morphine tolerance but lost fentanyl tolerance in hippocampal electrophysiology and antinociception assays","pmids":["14662727"],"confidence":"High","gaps":["Whether GRK3 directly phosphorylates KOR/MOR or acts indirectly","Relative contributions of GRK2 vs GRK3 to opioid tolerance"]},{"year":2006,"claim":"Demonstrating that GRK3 phosphorylation of KOR-Ser369 enables arrestin3-dependent p38 MAPK activation, and that GRK3-arrestin3 mediates MOR-ERK1/2 signaling, established GRK3 as a signaling scaffold beyond simple desensitization.","evidence":"GRK3 KO neurons lacked KOR-p38 and MOR-ERK activation; dominant-positive arrestin3-R170E rescued signaling; KOR-S369A mutant was refractory","pmids":["16648139","16982618"],"confidence":"High","gaps":["Structural basis of GRK3 selectivity for Ser369 on KOR","Whether GRK3-arrestin scaffolding occurs for non-opioid GPCRs"]},{"year":2007,"claim":"Identifying GRK3 as a specific desensitizer of cardiac α1-adrenergic receptors with blood pressure consequences defined a non-redundant cardiovascular role for GRK3 distinct from GRK2.","evidence":"Transgenic expression of dominant-negative GRK3ct enhanced α1-AR ERK signaling in myocytes and raised systolic blood pressure in mice","pmids":["18165681"],"confidence":"High","gaps":["Direct identification of α1-AR phosphorylation sites by GRK3","Whether GRK3 contributes to hypertension in human disease"]},{"year":2008,"claim":"Showing that GRK3 silencing phenocopied WHIM syndrome CXCR4 dysfunction — and GRK3 overexpression rescued it — identified GRK3 as the physiological kinase for CXCR4 desensitization in leukocytes.","evidence":"GRK3 siRNA in control leukocytes impaired CXCR4 internalization and chemotaxis; GRK3 overexpression in WHIM patient cells restored both","pmids":["18274673"],"confidence":"High","gaps":["CXCR4 phosphorylation sites preferentially targeted by GRK3 vs GRK2","Whether GRK3 variants contribute to WHIM-like phenotypes"]},{"year":2009,"claim":"Engineering the GRK3 C-terminal Gβγ-binding domain as a biosensor proved that this domain selectively recognizes free Gβγ, confirming a structural basis for GRK3 membrane recruitment.","evidence":"FRET/BRET with GRK3ct-fluorescent fusions showed binding to free Gβγ but not intact heterotrimers, resolving G protein dissociation kinetics (<100 ms)","pmids":["19258039"],"confidence":"High","gaps":["Whether endogenous GRK3 recruitment follows the same kinetics","Structural details of GRK3ct-Gβγ interface"]},{"year":2015,"claim":"Dissecting the RH domain function of GRK3 revealed a kinase-independent Gq-inhibitory mechanism, expanding GRK3's functional repertoire beyond phosphorylation.","evidence":"Kinase-dead GRK3 retained suppression of L-DOPA dyskinesia in hemiparkinsonian rats, but RH-domain-disabled GRK3 did not; RH domain bound striatal Gq directly","pmids":["26043205"],"confidence":"High","gaps":["Structural basis of RH domain-Gq interaction","Whether the RH domain contributes to GRK3 function at other Gq-coupled receptors"]},{"year":2020,"claim":"CRISPR dissection of GRK2/3 contributions to MOR internalization showed both kinases contribute with GRK2 dominant, and revealed a GRK2/3-independent β-arrestin2 recruitment component.","evidence":"CRISPR KO of GRK2, GRK3, or both in HEK293 cells with rescue; BRET β-arrestin2 recruitment and flow cytometry internalization across multiple agonists","pmids":["33060647"],"confidence":"High","gaps":["Phosphosite-level comparison of GRK2 vs GRK3 on MOR","Identity of the GRK-independent β-arrestin recruitment mechanism"]},{"year":2023,"claim":"Discovery that GRK3 phosphorylates the non-GPCR substrate HDAC2 at Ser394 to enhance epigenetic repression established a kinase-dependent oncogenic mechanism distinct from GPCR desensitization.","evidence":"Co-IP, in vitro phosphorylation, ChIP showing HDAC2 enrichment at TSP1/REST promoters, and xenograft models in prostate cancer","pmids":["37543278"],"confidence":"Medium","gaps":["Whether GRK3-HDAC2 interaction occurs outside prostate cancer contexts","Full phosphoproteomics of non-GPCR GRK3 substrates not performed"]},{"year":2024,"claim":"Identification of Gβ5 as a selective determinant distinguishing GRK3 from GRK2 membrane recruitment resolved a long-standing question about how two highly homologous kinases achieve substrate selectivity.","evidence":"CRISPR KO of Gβ subunits, single-molecule imaging of GRK3 at confined membrane domains enriched in Gβ5, BRET/FRET assays with biased MOR agonists","pmids":["39579957"],"confidence":"High","gaps":["Structural basis for Gβ5 selectivity toward GRK3 over GRK2","Whether Gβ5-GRK3 selectivity generalizes to all GPCR substrates"]},{"year":2024,"claim":"Demonstrating that GRK3 loss potentiates platelet GPCR signaling across Gq-, Gi-, and Gz-coupled receptors defined GRK3 as a broad platelet GPCR desensitizer relevant to hemostasis.","evidence":"GRK3 KO mouse platelets showed enhanced aggregation and secretion to multiple GPCR agonists but not collagen; shorter tail bleeding times in vivo","pmids":["39419098"],"confidence":"High","gaps":["Specific platelet GPCR phosphorylation sites targeted by GRK3","Whether GRK3 variants affect bleeding or thrombotic risk in humans"]},{"year":null,"claim":"The full spectrum of non-GPCR substrates of GRK3, the structural basis for Gβ5-mediated selective membrane recruitment, and whether GRK3 kinase vs RH domain functions are coordinately regulated remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No unbiased phosphoproteomics for GRK3 substrates","No high-resolution structure of GRK3 in complex with Gβ5 or Gq","Coordinate regulation of kinase and RH domain activities not addressed"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,3,6,7,11,18,20,22]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[14]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[12,23]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[8,12,23]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[8,12]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,3,6,7,10,11,14,18,22,23]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[11,17]},{"term_id":"R-HSA-109582","term_label":"Hemostasis","supporting_discovery_ids":[22]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[13,15,20]}],"complexes":[],"partners":["ARRB2","GNB5","GNAQ","HDAC2","RKIP","CXCR4","OPRK1","OPRM1"],"other_free_text":[]},"mechanistic_narrative":"GRK3 is a G protein-coupled receptor kinase that phosphorylates agonist-activated GPCRs to initiate β-arrestin recruitment, receptor desensitization, and internalization across diverse receptor systems including odorant, opioid, adrenergic, CRF1, CXCR4, and platelet GPCRs [PMID:9325250, PMID:18274673, PMID:39419098]. Beyond its kinase-dependent role, GRK3 inhibits Gq signaling through its RGS homology (RH) domain independently of catalytic activity, as demonstrated by suppression of L-DOPA-induced dyskinesia in a parkinsonian model [PMID:26043205]. GRK3 also phosphorylates the non-GPCR substrate HDAC2 at serine 394, enhancing epigenetic repression of tumor suppressors to promote angiogenesis and neuroendocrine differentiation in prostate cancer [PMID:37543278]. Selective membrane recruitment of GRK3 is governed by Gβ5-containing Gβγ dimers, distinguishing it from the closely related GRK2 [PMID:39579957]."},"prefetch_data":{"uniprot":{"accession":"P35626","full_name":"G protein-coupled receptor kinase 3","aliases":["Beta-adrenergic receptor kinase 2","Beta-ARK-2"],"length_aa":688,"mass_kda":79.7,"function":"receptors (By similarity). Also phosphorylates ligand-bound C3a and C5a anaphylatoxin receptors (C3AR1 and C5AR1, respectively), leading to receptor desensitization (PubMed:21799898)","subcellular_location":"Postsynapse; Presynapse","url":"https://www.uniprot.org/uniprotkb/P35626/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GRK3","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GRK3","total_profiled":1310},"omim":[{"mim_id":"607228","title":"MAS-RELATED G PROTEIN-COUPLED RECEPTOR FAMILY, MEMBER X2; MRGPRX2","url":"https://www.omim.org/entry/607228"},{"mim_id":"600474","title":"CATHELICIDIN ANTIMICROBIAL PEPTIDE; CAMP","url":"https://www.omim.org/entry/600474"},{"mim_id":"193670","title":"WHIM SYNDROME 1; WHIMS1","url":"https://www.omim.org/entry/193670"},{"mim_id":"109636","title":"BETA-ADRENERGIC RECEPTOR KINASE 2; ADRBK2","url":"https://www.omim.org/entry/109636"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adipose tissue","ntpm":19.8}],"url":"https://www.proteinatlas.org/search/GRK3"},"hgnc":{"alias_symbol":["BARK2"],"prev_symbol":["ADRBK2"]},"alphafold":{"accession":"P35626","domains":[{"cath_id":"1.10.167.10","chopping":"54-62_69-161","consensus_level":"high","plddt":89.2966,"start":54,"end":161},{"cath_id":"1.10.510.10","chopping":"278-343_350-476","consensus_level":"medium","plddt":94.6055,"start":278,"end":476},{"cath_id":"2.30.29.30","chopping":"557-659","consensus_level":"high","plddt":87.8475,"start":557,"end":659}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P35626","model_url":"https://alphafold.ebi.ac.uk/files/AF-P35626-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P35626-F1-predicted_aligned_error_v6.png","plddt_mean":89.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GRK3","jax_strain_url":"https://www.jax.org/strain/search?query=GRK3"},"sequence":{"accession":"P35626","fasta_url":"https://rest.uniprot.org/uniprotkb/P35626.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P35626/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P35626"}},"corpus_meta":[{"pmid":"16648139","id":"PMC_16648139","title":"Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16648139","citation_count":203,"is_preprint":false},{"pmid":"19258039","id":"PMC_19258039","title":"The c-terminus of GRK3 indicates rapid dissociation of G protein heterotrimers.","date":"2009","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/19258039","citation_count":147,"is_preprint":false},{"pmid":"9325250","id":"PMC_9325250","title":"G protein-coupled receptor kinase 3 (GRK3) gene disruption leads to loss of odorant receptor desensitization.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9325250","citation_count":129,"is_preprint":false},{"pmid":"18274673","id":"PMC_18274673","title":"Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling.","date":"2008","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/18274673","citation_count":109,"is_preprint":false},{"pmid":"14662727","id":"PMC_14662727","title":"G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal.","date":"2003","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/14662727","citation_count":85,"is_preprint":false},{"pmid":"16982618","id":"PMC_16982618","title":"Mu opioid receptor activation of ERK1/2 is GRK3 and arrestin dependent in striatal neurons.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16982618","citation_count":65,"is_preprint":false},{"pmid":"15728711","id":"PMC_15728711","title":"ATP stimulates GRK-3 phosphorylation and beta-arrestin-2-dependent internalization of P2X7 receptor.","date":"2005","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15728711","citation_count":59,"is_preprint":false},{"pmid":"9746479","id":"PMC_9746479","title":"Myocardial overexpression of GRK3 in transgenic mice: evidence for in vivo selectivity of GRKs.","date":"1998","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9746479","citation_count":52,"is_preprint":false},{"pmid":"32391018","id":"PMC_32391018","title":"ACKR4 Recruits GRK3 Prior to β-Arrestins but Can Scavenge Chemokines in the Absence of β-Arrestins.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32391018","citation_count":45,"is_preprint":false},{"pmid":"11247813","id":"PMC_11247813","title":"GRK3 mediates desensitization of CRF1 receptors: a potential mechanism regulating stress adaptation.","date":"2001","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11247813","citation_count":45,"is_preprint":false},{"pmid":"33060647","id":"PMC_33060647","title":"Dissecting the roles of GRK2 and GRK3 in μ-opioid receptor internalization and β-arrestin2 recruitment using CRISPR/Cas9-edited HEK293 cells.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33060647","citation_count":44,"is_preprint":false},{"pmid":"27191986","id":"PMC_27191986","title":"GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27191986","citation_count":41,"is_preprint":false},{"pmid":"7695743","id":"PMC_7695743","title":"Chromosome mapping of the human arrestin (SAG), beta-arrestin 2 (ARRB2), and beta-adrenergic receptor kinase 2 (ADRBK2) genes.","date":"1994","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7695743","citation_count":41,"is_preprint":false},{"pmid":"24434559","id":"PMC_24434559","title":"GRK3 is essential for metastatic cells and promotes prostate tumor progression.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24434559","citation_count":37,"is_preprint":false},{"pmid":"12413940","id":"PMC_12413940","title":"GRK3 regulation during CRF- and urocortin-induced CRF1 receptor desensitization.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12413940","citation_count":35,"is_preprint":false},{"pmid":"18165681","id":"PMC_18165681","title":"Cardiac-restricted expression of the carboxyl-terminal fragment of GRK3 Uncovers Distinct Functions of GRK3 in regulation of cardiac contractility and growth: GRK3 controls cardiac alpha1-adrenergic receptor responsiveness.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18165681","citation_count":30,"is_preprint":false},{"pmid":"20216086","id":"PMC_20216086","title":"beta-Adrenoceptor and GRK3 expression in human lymphocytes is related to blood pressure and urinary albumin excretion.","date":"2010","source":"Journal of hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/20216086","citation_count":24,"is_preprint":false},{"pmid":"21333691","id":"PMC_21333691","title":"Differential effects of inescapable stress on locus coeruleus GRK3, alpha2-adrenoceptor and CRF1 receptor levels in learned helpless and non-helpless rats: a potential link to stress resilience.","date":"2011","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/21333691","citation_count":23,"is_preprint":false},{"pmid":"16697355","id":"PMC_16697355","title":"Chronic treatment with mood stabilizers increases membrane GRK3 in rat frontal cortex.","date":"2006","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16697355","citation_count":20,"is_preprint":false},{"pmid":"18075471","id":"PMC_18075471","title":"Further evidence for association of GRK3 to bipolar disorder suggests a second disease mutation.","date":"2007","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18075471","citation_count":17,"is_preprint":false},{"pmid":"12642394","id":"PMC_12642394","title":"Desensitization of alpha 2A-adrenoceptor signalling by modest levels of adrenaline is facilitated by beta 2-adrenoceptor-dependent GRK3 up-regulation.","date":"2003","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12642394","citation_count":17,"is_preprint":false},{"pmid":"26043205","id":"PMC_26043205","title":"GRK3 suppresses L-DOPA-induced dyskinesia in the rat model of Parkinson's disease via its RGS homology domain.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26043205","citation_count":17,"is_preprint":false},{"pmid":"31306812","id":"PMC_31306812","title":"Pharmacological antagonism of histamine H2R ameliorated L-DOPA-induced dyskinesia via normalization of GRK3 and by suppressing FosB and ERK in PD.","date":"2019","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/31306812","citation_count":16,"is_preprint":false},{"pmid":"19400979","id":"PMC_19400979","title":"Decreased GRK3 but not GRK2 expression in frontal cortex from bipolar disorder patients.","date":"2009","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19400979","citation_count":13,"is_preprint":false},{"pmid":"17583697","id":"PMC_17583697","title":"Activation of the CRF(1) receptor causes ERK1/2 mediated increase in GRK3 expression in CATH.a cells.","date":"2007","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/17583697","citation_count":12,"is_preprint":false},{"pmid":"17106420","id":"PMC_17106420","title":"Bipolar 1 disorder is not associated with the RGS4, PRODH, COMT and GRK3 genes.","date":"2006","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17106420","citation_count":12,"is_preprint":false},{"pmid":"33976392","id":"PMC_33976392","title":"GRK3 deficiency elicits brain immune activation and psychosis.","date":"2021","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/33976392","citation_count":11,"is_preprint":false},{"pmid":"21916780","id":"PMC_21916780","title":"Activity of β2-adrenergic receptor in oral squamous cell carcinoma is mediated by overexpression of the ADRBK2 gene: a pilot study.","date":"2011","source":"Biotechnic & histochemistry : official publication of the Biological Stain Commission","url":"https://pubmed.ncbi.nlm.nih.gov/21916780","citation_count":10,"is_preprint":false},{"pmid":"37543278","id":"PMC_37543278","title":"A novel GRK3-HDAC2 regulatory pathway is a key direct link between neuroendocrine differentiation and angiogenesis in prostate cancer progression.","date":"2023","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/37543278","citation_count":9,"is_preprint":false},{"pmid":"31604529","id":"PMC_31604529","title":"The N-termini of GRK2 and GRK3 simulate the stimulating effects of RKIP on β-adrenoceptors.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31604529","citation_count":8,"is_preprint":false},{"pmid":"19766236","id":"PMC_19766236","title":"Allele specific analysis of the ADRBK2 gene in lymphoblastoid cells from bipolar disorder patients.","date":"2009","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/19766236","citation_count":8,"is_preprint":false},{"pmid":"16359584","id":"PMC_16359584","title":"Lymphocyte G-protein receptor kinase (GRK)3 mRNA levels in bipolar disorder.","date":"2005","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16359584","citation_count":8,"is_preprint":false},{"pmid":"36907139","id":"PMC_36907139","title":"TEAD3 inhibits the proliferation and metastasis of prostate cancer via suppressing ADRBK2.","date":"2023","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/36907139","citation_count":6,"is_preprint":false},{"pmid":"17621168","id":"PMC_17621168","title":"Association analysis of GRK3 gene promoter variants in cocaine abuse.","date":"2007","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17621168","citation_count":5,"is_preprint":false},{"pmid":"38714850","id":"PMC_38714850","title":"TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells.","date":"2024","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/38714850","citation_count":4,"is_preprint":false},{"pmid":"39579957","id":"PMC_39579957","title":"Signal profiles and spatial regulation of β-arrestin recruitment through Gβ5 and GRK3 at the μ-opioid receptor.","date":"2024","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39579957","citation_count":2,"is_preprint":false},{"pmid":"37048054","id":"PMC_37048054","title":"Aged G Protein-Coupled Receptor Kinase 3 (Grk3)-Deficient Mice Exhibit Enhanced Osteoclastogenesis and Develop Bone Lesions Analogous to Human Paget's Disease of Bone.","date":"2023","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/37048054","citation_count":1,"is_preprint":false},{"pmid":"39419098","id":"PMC_39419098","title":"Distinct Role of GRK3 in Platelet Activation by Desensitization of G Protein-Coupled Receptors.","date":"2024","source":"Thrombosis and haemostasis","url":"https://pubmed.ncbi.nlm.nih.gov/39419098","citation_count":0,"is_preprint":false},{"pmid":"29884935","id":"PMC_29884935","title":"G Protein-Coupled Receptor Kinase 3 (GRK3) in Olfaction.","date":"2018","source":"Methods in molecular biology (Clifton, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/29884935","citation_count":0,"is_preprint":false},{"pmid":"17433264","id":"PMC_17433264","title":"Regulatory mechanisms underlying GKR2 levels in U937 cells: evidence for GRK3 involvement.","date":"2007","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17433264","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.04.21.649864","title":"Parallel CRISPR screens reveal pathways controlling the cell surface levels of the attractant receptor FPR1","date":"2025-04-23","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.21.649864","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":21561,"output_tokens":5842,"usd":0.076157},"stage2":{"model":"claude-opus-4-6","input_tokens":9455,"output_tokens":3400,"usd":0.198412},"total_usd":0.274569,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1997,\n      \"finding\": \"GRK3 is required for agonist-induced desensitization of odorant receptors in the olfactory epithelium; GRK3 knockout mice lack fast agonist-induced desensitization and show markedly reduced cAMP generation following odorant stimulation.\",\n      \"method\": \"GRK3 knockout mice, cilia preparation cAMP assay, odorant stimulation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype, replicated across multiple stimuli\",\n      \"pmids\": [\"9325250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Cardiac overexpression of GRK3 selectively attenuates thrombin-induced p42/p44 MAP kinase activation but does not desensitize beta-adrenergic or angiotensin II receptors in vivo, demonstrating distinct substrate specificity of GRK3 in the heart.\",\n      \"method\": \"Transgenic mice with cardiac-specific GRK3 overexpression, in vivo hemodynamic measurements, MAP kinase activation assays\",\n      \"journal\": \"The American journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — transgenic animal model with multiple receptor/signaling readouts\",\n      \"pmids\": [\"9746479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"GRK3 mediates homologous desensitization of CRF1 receptors; GRK3 antisense knockdown (~50% reduction in GRK3 protein) inhibited CRF1 receptor desensitization by ~65% in Y-79 cells, while PKA inhibition had no effect.\",\n      \"method\": \"GRK3 antisense oligonucleotide and antisense cDNA transfection, cAMP accumulation assay, heparin GRK inhibition\",\n      \"journal\": \"American journal of physiology. Regulatory, integrative and comparative physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple antisense approaches with functional readout, single lab\",\n      \"pmids\": [\"11247813\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GRK3-mediated mechanisms are required for electrophysiological and behavioral tolerance to the high-efficacy opioid fentanyl but not morphine; GRK3 knockout mice show significantly reduced fentanyl tolerance in hippocampal slices and antinociceptive assays.\",\n      \"method\": \"GRK3 knockout mice, hippocampal slice electrophysiology, hot-plate antinociception assay\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with both in vitro and in vivo phenotypic readouts\",\n      \"pmids\": [\"14662727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Beta2-adrenoceptor activation upregulates GRK3 expression, which in turn mediates desensitization and downregulation of alpha2A-adrenoceptors; GRK2/3 antisense DNA blocked chronic adrenaline-induced alpha2A-AR desensitization.\",\n      \"method\": \"GRK2/3 antisense DNA, receptor binding assay, beta-AR antagonist propranolol blockade, immunoblotting\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — antisense knockdown with functional assay, single lab\",\n      \"pmids\": [\"12642394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"ATP stimulates GRK3 binding to the P2X7 receptor, followed by beta-arrestin-2 and dynamin recruitment, leading to clathrin-dependent internalization of the receptor.\",\n      \"method\": \"Western blot co-immunoprecipitation, pore formation assay, immunofluorescence of beta-arrestin-2 redistribution\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP/pulldown evidence for GRK3-P2X7 interaction, single lab\",\n      \"pmids\": [\"15728711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"KOR activation of p38 MAPK requires GRK3-mediated phosphorylation of serine-369 on KOR and subsequent arrestin3 recruitment; p38 activation was absent in GRK3 knockout neurons and astrocytes, and was rescued by dominant-positive arrestin3-(R170E).\",\n      \"method\": \"GRK3 knockout mice, AtT-20 cells with KSA mutant receptor, dominant-positive arrestin3-(R170E) transfection, phospho-p38 immunolabeling, siRNA for arrestin3\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches (KO mice, receptor mutant, dominant-positive arrestin, siRNA) across two cell types\",\n      \"pmids\": [\"16648139\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Mu opioid receptor activation of ERK1/2 in striatal neurons requires GRK3 and arrestin3; ERK1/2 activation by fentanyl was absent in GRK3-/- neurons and restored by dominant-positive arrestin3-(R170E), and was not induced by morphine (lower efficacy) unless dominant-positive arrestin was co-expressed.\",\n      \"method\": \"GRK3 knockout mice, MOR knockout mice, dominant-positive arrestin3-(R170E) transfection, siRNA for arrestin3, MEK inhibitor U0126, ERK1/2 phosphorylation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches (KO, dominant-positive arrestin, siRNA, inhibitor) in primary neurons\",\n      \"pmids\": [\"16982618\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Chronic treatment with lithium or carbamazepine (but not valproate) increases translocation of GRK3 from cytosol to membrane fraction in rat frontal cortex.\",\n      \"method\": \"Immunoblotting of membrane and cytosol fractions from drug-treated rats\",\n      \"journal\": \"Biological psychiatry\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single method (immunoblot), single lab, no direct mechanistic follow-up\",\n      \"pmids\": [\"16697355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"CRF activates CRF1 receptors to upregulate GRK3 expression via an ERK1/2-mediated mechanism involving Sp-1 and Ap-2 transcription factors in CATH.a cells (locus coeruleus-derived).\",\n      \"method\": \"ERK1/2 inhibitors, transcription factor activity assays (Sp-1, Ap-2), GRK3 mRNA/protein quantification\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — functional pathway inhibition with transcription factor identification, single lab\",\n      \"pmids\": [\"17583697\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Inhibition of cardiac GRK3 (via expression of GRK3ct) enhances alpha1-adrenergic receptor-mediated ERK1/2 activation in cardiac myocytes and increases systolic blood pressure and cardiac output in vivo, demonstrating that GRK3 specifically desensitizes alpha1-adrenergic receptors in the heart.\",\n      \"method\": \"Transgenic mice expressing GRK3ct competitive inhibitor, cardiac myocyte ERK1/2 assay, conductance micromanometry, tail-cuff plethysmography, radiotelemetric blood pressure recording\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — transgenic competitive inhibitor with multiple in vivo functional readouts\",\n      \"pmids\": [\"18165681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GRK3 specifically regulates CXCL12-promoted internalization and desensitization of CXCR4; GRK3 silencing in control leukocytes phenocopied impaired CXCR4 attenuation seen in WHIM syndrome cells, and GRK3 overexpression in WHIM patient cells restored normal CXCR4 internalization and chemotaxis.\",\n      \"method\": \"GRK3 siRNA knockdown, GRK3 overexpression in patient leukocytes and fibroblasts, CXCR4 internalization assay, chemotaxis assay\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain/loss-of-function with defined cellular phenotype, patient cell validation\",\n      \"pmids\": [\"18274673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The C-terminus of GRK3 (GRK3ct) fused to fluorescent reporters binds free Gbetagamma dimers but not intact heterotrimers, enabling real-time reporting of G protein heterotrimer dissociation; using this probe, heterotrimer dissociation in living cells was shown to occur in less than 100 ms.\",\n      \"method\": \"FRET/BRET with GRK3ct fusion proteins and venus-labeled Gbetagamma, live-cell imaging, kinetic analysis\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstitution of GRK3ct-Gbetagamma interaction with FRET/BRET, multiple controls\",\n      \"pmids\": [\"19258039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GRK3 promotes prostate cancer metastasis and angiogenesis, at least in part through downregulation of thrombospondin-1 and plasminogen activator inhibitor type 2; GRK3 is necessary for survival/proliferation of metastatic cells and sufficient to promote primary tumor growth in mouse xenograft models.\",\n      \"method\": \"RNAi screen, cDNA overexpression screen, mouse xenograft models, angiogenesis assays, protein expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo gain/loss of function with mechanistic targets identified, single lab\",\n      \"pmids\": [\"24434559\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GRK3 suppresses L-DOPA-induced dyskinesia via its RGS homology (RH) domain, which binds striatal Gq; kinase-dead GRK3 retains suppressive activity, but GRK3 with disabled RH domain does not, indicating the RH domain mediates Gq inhibition independently of kinase activity.\",\n      \"method\": \"Viral vector-mediated overexpression and microRNA knockdown in hemiparkinsonian rats, domain mutant analysis, Gq binding assay, ΔFosB immunohistochemistry\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — domain dissection with multiple mutants, in vivo model, and direct binding of RH domain to Gq\",\n      \"pmids\": [\"26043205\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CREB directly targets and induces GRK3 transcription; GRK3 promotes neuroendocrine differentiation of prostate cancer cells in a kinase activity-dependent manner, and GRK3 silencing blocks CREB-induced neuroendocrine differentiation.\",\n      \"method\": \"ChIP/promoter analysis for CREB binding, GRK3 overexpression with kinase-dead controls, siRNA knockdown, NE marker expression assays\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct CREB-GRK3 promoter targeting plus kinase-activity-dependent functional assay, single lab\",\n      \"pmids\": [\"27191986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RKIP binds specifically to the N-termini of GRK2 and GRK3 (not GRK5); the isolated N-terminal domains (GRK2/3 residues 1-185) interact directly with beta2-AR, prevent its phosphorylation and internalization, and increase receptor signaling and cardiomyocyte contractility.\",\n      \"method\": \"Co-immunoprecipitation, pull-down assays, beta2-AR phosphorylation assay, receptor internalization assay, cardiomyocyte contractility measurement\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP and pulldown with functional receptor and contractility assays, single lab\",\n      \"pmids\": [\"31604529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GRK3 is recruited to chemokine-stimulated ACKR4 prior to beta-arrestins, and GRK2/3 inhibition partially blocks steady-state and chemokine-driven beta-arrestin recruitment to ACKR4, placing GRK3 upstream of beta-arrestin in ACKR4 trafficking.\",\n      \"method\": \"BRET-based GRK and beta-arrestin recruitment assays, GRK2/3 pharmacological inhibition, ACKR4 C-terminus deletion, fluorescent chemokine uptake assay\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — multiple BRET and functional assays in single lab establishing recruitment hierarchy\",\n      \"pmids\": [\"32391018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GRK2 and GRK3 are both required for mu-opioid receptor internalization and beta-arrestin2 recruitment; GRK2 contributes more than GRK3, and a GRK2/3-independent component of beta-arrestin2 recruitment exists at the plasma membrane.\",\n      \"method\": \"CRISPR/Cas9 knockout of GRK2, GRK3, or both in HEK293 cells; rescue expression; CMPD101 pharmacological inhibition; BRET-based beta-arrestin2 recruitment; flow cytometry internalization assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — CRISPR KO with rescue, pharmacological validation, multiple agonists and orthogonal readouts\",\n      \"pmids\": [\"33060647\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GRK3 deficiency in mice leads to elevated brain IL-1β, increased kynurenic acid turnover, hyper-responsiveness to D-amphetamine, elevated spontaneous firing of midbrain dopamine neurons, and disruption in prepulse inhibition, linking GRK3 to immune/glial activation and dopaminergic dysregulation.\",\n      \"method\": \"Grk3-/- mice, behavioral assays, electrophysiology, biochemical (IL-1β, KYNA measurements), molecular imaging\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in KO mice, single lab\",\n      \"pmids\": [\"33976392\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GRK3 phosphorylates HDAC2 at serine 394, enhancing HDAC2's epigenetic repression of TSP1 and REST, thereby promoting angiogenesis and neuroendocrine differentiation in prostate cancer.\",\n      \"method\": \"Co-IP, phosphorylation assay (GRK3-HDAC2 at S394), ChIP, luciferase reporter assay, siRNA/overexpression, in vivo xenograft\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct phosphorylation of HDAC2 by GRK3 identified with multiple downstream functional assays, single lab\",\n      \"pmids\": [\"37543278\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GRK3 deficiency enhances osteoclastogenesis and proliferation of hematopoietic osteoclast precursors in vitro and in vivo; aged Grk3-/- mice develop bone lesions resembling Paget's Disease of Bone.\",\n      \"method\": \"Grk3-/- mice, in vitro osteoclast differentiation assay, flow cytometry of hematopoietic precursors, histological analysis\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse model with multiple cellular and in vivo phenotypic readouts, single lab\",\n      \"pmids\": [\"37048054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GRK3 plays a distinct role in platelet GPCR desensitization: GRK3-/- platelets show potentiated aggregation and secretion in response to multiple GPCR agonists (including Gq-, Gi-, and Gz-coupled receptors) but not to the non-GPCR agonist collagen; GRK3-/- mice show shorter tail bleeding times.\",\n      \"method\": \"GRK3 knockout mice, platelet aggregation assay, dense granule secretion assay, AKT and ERK phosphorylation, tail bleeding time\",\n      \"journal\": \"Thrombosis and haemostasis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple agonist/receptor readouts and in vivo hemostasis assay\",\n      \"pmids\": [\"39419098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Gβ5 selectively distinguishes GRK3 from GRK2 and enables GRK3 recruitment to the plasma membrane upon MOR activation; GRK3 is recruited to confined membrane domains enriched in Gβ5 (via single-molecule imaging), and oliceridine (a G-protein-biased MOR agonist) selectively activates GRK3-mediated beta-arrestin recruitment via Gαz-Gβ5 signaling.\",\n      \"method\": \"Multiple CRISPR-edited cell lines, BRET/FRET functional assays, single-molecule imaging, particle diffusion analysis\",\n      \"journal\": \"European journal of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — single-molecule imaging, CRISPR KO of specific Gβ subunits, multiple orthogonal assays\",\n      \"pmids\": [\"39579957\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GRK3 regulates GRK2 protein levels in U937 cells via a mechanism involving inositol phosphate (InsP) upregulation; GRK3 antisense knockdown decreased GRK2 levels, establishing a novel cross-regulatory mechanism between GRK family members.\",\n      \"method\": \"Antisense knockdown of GRK3, immunoblotting for GRK2, InsP measurement\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single method (antisense + immunoblot), indirect mechanism, single lab\",\n      \"pmids\": [\"17433264\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GRK2, GRK3, and GRK6 are all important for FPR1 internalization in neutrophil-like cells, as identified by genome-wide CRISPR/Cas9 screens; FPR1 uses multiple endocytic pathways since cells lacking beta-arrestins show strong but incomplete internalization defects.\",\n      \"method\": \"Genome-wide CRISPR/Cas9 screens, FPR1 surface expression and internalization assays, beta-arrestin knockout validation\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide screen with orthogonal validation, preprint\",\n      \"pmids\": [\"bio_10.1101_2025.04.21.649864\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"GRK3 is a serine/threonine GPCR kinase that phosphorylates activated GPCRs (including opioid, odorant, adrenergic, CRF1, CXCR4, and platelet receptors) to promote beta-arrestin recruitment and receptor desensitization/internalization, and additionally signals through its RGS homology domain to inhibit Gq, while its C-terminal Gbetagamma-binding domain is used to probe G protein heterotrimer dissociation dynamics, and its kinase activity can phosphorylate non-GPCR substrates such as HDAC2 to regulate epigenetic programs in cancer.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GRK3 is a G protein-coupled receptor kinase that phosphorylates agonist-activated GPCRs to initiate β-arrestin recruitment, receptor desensitization, and internalization across diverse receptor systems including odorant, opioid, adrenergic, CRF1, CXCR4, and platelet GPCRs [PMID:9325250, PMID:18274673, PMID:39419098]. Beyond its kinase-dependent role, GRK3 inhibits Gq signaling through its RGS homology (RH) domain independently of catalytic activity, as demonstrated by suppression of L-DOPA-induced dyskinesia in a parkinsonian model [PMID:26043205]. GRK3 also phosphorylates the non-GPCR substrate HDAC2 at serine 394, enhancing epigenetic repression of tumor suppressors to promote angiogenesis and neuroendocrine differentiation in prostate cancer [PMID:37543278]. Selective membrane recruitment of GRK3 is governed by Gβ5-containing Gβγ dimers, distinguishing it from the closely related GRK2 [PMID:39579957].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Establishing that GRK3 is a physiologically essential GPCR kinase for sensory receptor desensitization resolved whether GRK2 and GRK3 had redundant functions in vivo.\",\n      \"evidence\": \"GRK3 knockout mice showed abolished fast odorant-induced desensitization and reduced cAMP generation in olfactory cilia\",\n      \"pmids\": [\"9325250\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GRK3 phosphorylation sites on odorant receptors were mapped\", \"Whether GRK2 can partially compensate in olfactory neurons over longer timescales\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrating cardiac substrate selectivity of GRK3 established that GRK isoforms have non-overlapping receptor preferences even within the same tissue.\",\n      \"evidence\": \"Transgenic cardiac GRK3 overexpression attenuated thrombin-induced MAPK signaling but not β-adrenergic or angiotensin II receptor responses in mouse heart\",\n      \"pmids\": [\"9746479\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the thrombin receptor (PAR) phosphorylation sites targeted by GRK3\", \"Whether endogenous GRK3 levels limit thrombin signaling under physiological conditions\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identifying GRK3 as the kinase mediating CRF1 receptor desensitization extended its substrate repertoire to stress-related neuropeptide receptors.\",\n      \"evidence\": \"GRK3 antisense knockdown inhibited CRF1 desensitization by ~65% in Y-79 cells while PKA inhibition had no effect\",\n      \"pmids\": [\"11247813\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Awaits confirmation by genetic knockout or CRISPR approaches\", \"CRF1 phosphorylation sites targeted by GRK3 not mapped\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showing that GRK3 is required for tolerance to high-efficacy but not low-efficacy opioids revealed an agonist-efficacy threshold for GRK3-dependent desensitization, a principle later extended to MOR-ERK signaling.\",\n      \"evidence\": \"GRK3 knockout mice retained morphine tolerance but lost fentanyl tolerance in hippocampal electrophysiology and antinociception assays\",\n      \"pmids\": [\"14662727\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GRK3 directly phosphorylates KOR/MOR or acts indirectly\", \"Relative contributions of GRK2 vs GRK3 to opioid tolerance\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrating that GRK3 phosphorylation of KOR-Ser369 enables arrestin3-dependent p38 MAPK activation, and that GRK3-arrestin3 mediates MOR-ERK1/2 signaling, established GRK3 as a signaling scaffold beyond simple desensitization.\",\n      \"evidence\": \"GRK3 KO neurons lacked KOR-p38 and MOR-ERK activation; dominant-positive arrestin3-R170E rescued signaling; KOR-S369A mutant was refractory\",\n      \"pmids\": [\"16648139\", \"16982618\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of GRK3 selectivity for Ser369 on KOR\", \"Whether GRK3-arrestin scaffolding occurs for non-opioid GPCRs\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identifying GRK3 as a specific desensitizer of cardiac α1-adrenergic receptors with blood pressure consequences defined a non-redundant cardiovascular role for GRK3 distinct from GRK2.\",\n      \"evidence\": \"Transgenic expression of dominant-negative GRK3ct enhanced α1-AR ERK signaling in myocytes and raised systolic blood pressure in mice\",\n      \"pmids\": [\"18165681\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct identification of α1-AR phosphorylation sites by GRK3\", \"Whether GRK3 contributes to hypertension in human disease\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Showing that GRK3 silencing phenocopied WHIM syndrome CXCR4 dysfunction — and GRK3 overexpression rescued it — identified GRK3 as the physiological kinase for CXCR4 desensitization in leukocytes.\",\n      \"evidence\": \"GRK3 siRNA in control leukocytes impaired CXCR4 internalization and chemotaxis; GRK3 overexpression in WHIM patient cells restored both\",\n      \"pmids\": [\"18274673\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"CXCR4 phosphorylation sites preferentially targeted by GRK3 vs GRK2\", \"Whether GRK3 variants contribute to WHIM-like phenotypes\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Engineering the GRK3 C-terminal Gβγ-binding domain as a biosensor proved that this domain selectively recognizes free Gβγ, confirming a structural basis for GRK3 membrane recruitment.\",\n      \"evidence\": \"FRET/BRET with GRK3ct-fluorescent fusions showed binding to free Gβγ but not intact heterotrimers, resolving G protein dissociation kinetics (<100 ms)\",\n      \"pmids\": [\"19258039\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether endogenous GRK3 recruitment follows the same kinetics\", \"Structural details of GRK3ct-Gβγ interface\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Dissecting the RH domain function of GRK3 revealed a kinase-independent Gq-inhibitory mechanism, expanding GRK3's functional repertoire beyond phosphorylation.\",\n      \"evidence\": \"Kinase-dead GRK3 retained suppression of L-DOPA dyskinesia in hemiparkinsonian rats, but RH-domain-disabled GRK3 did not; RH domain bound striatal Gq directly\",\n      \"pmids\": [\"26043205\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of RH domain-Gq interaction\", \"Whether the RH domain contributes to GRK3 function at other Gq-coupled receptors\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"CRISPR dissection of GRK2/3 contributions to MOR internalization showed both kinases contribute with GRK2 dominant, and revealed a GRK2/3-independent β-arrestin2 recruitment component.\",\n      \"evidence\": \"CRISPR KO of GRK2, GRK3, or both in HEK293 cells with rescue; BRET β-arrestin2 recruitment and flow cytometry internalization across multiple agonists\",\n      \"pmids\": [\"33060647\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphosite-level comparison of GRK2 vs GRK3 on MOR\", \"Identity of the GRK-independent β-arrestin recruitment mechanism\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Discovery that GRK3 phosphorylates the non-GPCR substrate HDAC2 at Ser394 to enhance epigenetic repression established a kinase-dependent oncogenic mechanism distinct from GPCR desensitization.\",\n      \"evidence\": \"Co-IP, in vitro phosphorylation, ChIP showing HDAC2 enrichment at TSP1/REST promoters, and xenograft models in prostate cancer\",\n      \"pmids\": [\"37543278\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether GRK3-HDAC2 interaction occurs outside prostate cancer contexts\", \"Full phosphoproteomics of non-GPCR GRK3 substrates not performed\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identification of Gβ5 as a selective determinant distinguishing GRK3 from GRK2 membrane recruitment resolved a long-standing question about how two highly homologous kinases achieve substrate selectivity.\",\n      \"evidence\": \"CRISPR KO of Gβ subunits, single-molecule imaging of GRK3 at confined membrane domains enriched in Gβ5, BRET/FRET assays with biased MOR agonists\",\n      \"pmids\": [\"39579957\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for Gβ5 selectivity toward GRK3 over GRK2\", \"Whether Gβ5-GRK3 selectivity generalizes to all GPCR substrates\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstrating that GRK3 loss potentiates platelet GPCR signaling across Gq-, Gi-, and Gz-coupled receptors defined GRK3 as a broad platelet GPCR desensitizer relevant to hemostasis.\",\n      \"evidence\": \"GRK3 KO mouse platelets showed enhanced aggregation and secretion to multiple GPCR agonists but not collagen; shorter tail bleeding times in vivo\",\n      \"pmids\": [\"39419098\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific platelet GPCR phosphorylation sites targeted by GRK3\", \"Whether GRK3 variants affect bleeding or thrombotic risk in humans\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The full spectrum of non-GPCR substrates of GRK3, the structural basis for Gβ5-mediated selective membrane recruitment, and whether GRK3 kinase vs RH domain functions are coordinately regulated remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No unbiased phosphoproteomics for GRK3 substrates\", \"No high-resolution structure of GRK3 in complex with Gβ5 or Gq\", \"Coordinate regulation of kinase and RH domain activities not addressed\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 3, 6, 7, 11, 18, 20, 22]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [14]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [12, 23]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [8, 12, 23]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [8, 12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 3, 6, 7, 10, 11, 14, 18, 22, 23]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [11, 17]},\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [22]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [13, 15, 20]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"ARRB2\",\n      \"GNB5\",\n      \"GNAQ\",\n      \"HDAC2\",\n      \"RKIP\",\n      \"CXCR4\",\n      \"OPRK1\",\n      \"OPRM1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}